Reasons to Watch: China Lodging Group, Limited (NASDAQ:HTHT), Control4 Corporation (NASDAQ:CTRL), AmpliPhi Biosciences Corporation (NYSEMKT:APHB), Agenus (NASDAQ:AGEN)

Posted by on Oct 09, 2015

Helen of Troy Limited (NASDAQ:HELE) shares moved down -0.39% in last trading session and ended the day at $94.76. HELE Gross Margin is 42.20% and its has a return on assets of 7.90%. Helen of Troy Limited (NASDAQ:HELE) quarterly performance is 9.28%.

Helen Of Troy (NASDAQ: HELE) reported Q2 EPS of $1.12, $0.19 better than the analyst estimate of $0.93. Revenue for the quarter came in at $369.1 million versus the consensus estimate of $337.67 million. Helen Of Troy sees FY2016 EPS of $5.50-$5.85, versus prior guidance of $5.40-$5.85 and the consensus of $5.45. Helen Of Troy sees FY2016 revenue of $1.5-1.536 billion, versus the consensus of $1.51 billion.

China Lodging Group, Limited (NASDAQ:HTHT) ended the last trading day at $26.48. Company weekly volatility is calculated as 3.94% and price to cash ratio as 9.07. China Lodging Group, Limited (NASDAQ:HTHT) showed a weekly performance of 8.48%.

On 08 October, Control4 Corporation (NASDAQ:CTRL) shares moved up 3.37% and was closed at $8.89. CTRL EPS growth in last 5 year was 15.50%. Control4 Corporation (NASDAQ:CTRL) year to date (YTD) performance is -42.16%.

Control4 Corporation (NASDAQ:CTRL) was recently named Custom Integration (CI) Vendor of the Year at the Home Technology Specialists of America (HTSA) 2015 Fall Conference held in Chicago last week. The membership of HTSA comprises more than 70 of the nation’s largest Custom Integrator businesses and over 60 popular consumer electronics manufacturers as vendors. The award for CI Vendor of the Year is given to the manufacturer that best aligns with the ideals of HTSA and drives significant business growth for its membership.

AmpliPhi Biosciences Corporation (NYSEMKT:APHB) shares moved up 11.26% in last trading session and ended the day at $5.73. APHB has a return on assets of 41.60%.

Roth Capital reaffirmed their buy rating on shares of Ampliphi Biosciences Corp (NYSEMKTS:APHB) in a research note published on Tuesday morning, Market Beat reports.

Agenus Inc. (NASDAQ:AGEN) caters to the Healthcare space. Its weekly performance is 5.29%. On the last day of trading company shares ended up at $4.78. Agenus Inc. (NASDAQ:AGEN) distance from 50-day simple moving average (SMA50) is -28.79%.

Agenus Inc. (NASDAQ: AGEN), an immunology company discovering and developing innovative treatments for cancers and other diseases, announced a $115 million non-dilutive royalty transaction pursuant to a Note Purchase Agreement with an investor group led by Oberland Capital Management, LLC (Oberland Capital). Agenus intends to use the proceeds from this transaction to advance its immuno-oncology programs.

Leave a Reply

Your email address will not be published. Required fields are marked *